These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

130 related articles for article (PubMed ID: 17653913)

  • 21. JWA is required for arsenic trioxide induced apoptosis in HeLa and MCF-7 cells via reactive oxygen species and mitochondria linked signal pathway.
    Zhou J; Ye J; Zhao X; Li A; Zhou J
    Toxicol Appl Pharmacol; 2008 Jul; 230(1):33-40. PubMed ID: 18387645
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Lung infiltration of adult T-cell leukemia cells following the administration of arsenic trioxide. Lung infiltration of ATL by AS(2)O(3).
    Tsutsumi Y; Kanamori H; Yamato H; Ehira N; Kawamura T; Obara S; Tanaka J; Asaka M; Imamura M; Masauzi N
    Med Hypotheses; 2006; 66(1):201-2. PubMed ID: 16165312
    [No Abstract]   [Full Text] [Related]  

  • 23. Clinical activity of arsenic trioxide in Burkitt-like lymphoma.
    Ravandi F; van Besien K
    Leukemia; 2003 Jan; 17(1):271-2. PubMed ID: 12529694
    [No Abstract]   [Full Text] [Related]  

  • 24. Effects of arsenic trioxide on voltage-dependent potassium channels and on cell proliferation of human multiple myeloma cells.
    Zhou J; Wang W; Wei QF; Feng TM; Tan LJ; Yang BF
    Chin Med J (Engl); 2007 Jul; 120(14):1266-9. PubMed ID: 17697580
    [No Abstract]   [Full Text] [Related]  

  • 25. Chinese folk treatment reveals power of arsenic to treat cancer, new studies under way.
    Hede K
    J Natl Cancer Inst; 2007 May; 99(9):667-8. PubMed ID: 17470732
    [No Abstract]   [Full Text] [Related]  

  • 26. [Progress of arsenic trioxide in treating myelodysplastic syndromes].
    Xu S; Ma R
    Zhongguo Zhong Xi Yi Jie He Za Zhi; 2009 Jan; 29(1):83-4. PubMed ID: 19338160
    [No Abstract]   [Full Text] [Related]  

  • 27. Combination brings long-term remission in acute promyelocytic leukemia refractory for both all-trans retinoic acid and arsenic trioxide.
    Sasaki M; Sugimoto K; Isobe Y; Oshimi K
    Eur J Haematol; 2008 Aug; 81(2):160. PubMed ID: 18363868
    [No Abstract]   [Full Text] [Related]  

  • 28. Antimony-trioxide- and arsenic-trioxide-induced apoptosis in myelogenic and lymphatic cell lines, recruitment of caspases, and loss of mitochondrial membrane potential are enhanced by modulators of the cellular glutathione redox system.
    Lösler S; Schlief S; Kneifel C; Thiel E; Schrezenmeier H; Rojewski MT
    Ann Hematol; 2009 Nov; 88(11):1047-58. PubMed ID: 19301004
    [TBL] [Abstract][Full Text] [Related]  

  • 29. What is the role of arsenic in newly diagnosed APL?
    Tallman MS
    Best Pract Res Clin Haematol; 2008 Dec; 21(4):659-66. PubMed ID: 19041605
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Comparison of clinical outcomes of patients with relapsed acute promyelocytic leukemia induced with arsenic trioxide and consolidated with either an autologous stem cell transplant or an arsenic trioxide-based regimen.
    Thirugnanam R; George B; Chendamarai E; Lakshmi KM; Balasubramanian P; Viswabandya A; Srivastava A; Chandy M; Mathews V
    Biol Blood Marrow Transplant; 2009 Nov; 15(11):1479-84. PubMed ID: 19822309
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Second hematological malignancies during arsenic trioxide therapy of B-cell lymphomas.
    Au WY; Tam S; Fong BM; Wan TS; Yip SF; Kwong YL
    Leuk Res; 2009 Jan; 33(1):191-3. PubMed ID: 18495244
    [No Abstract]   [Full Text] [Related]  

  • 32. Arsenic trioxide for refractory aplastic anemia.
    Lin Q; Song Y; Fang B
    Ann Hematol; 2013 Mar; 92(3):431-2. PubMed ID: 23064943
    [No Abstract]   [Full Text] [Related]  

  • 33. [Effects of arsenic trioxide on Id4 methylation status in bone marrow mononuclear cells and its clinical efficacy for myelodysplastic syndrome].
    Shao X; Lu R; Guan X; Liu J; Zhao J; Shao Z; Zhan Z; Ma J
    Zhonghua Xue Ye Xue Za Zhi; 2014 Mar; 35(3):247-50. PubMed ID: 24666496
    [No Abstract]   [Full Text] [Related]  

  • 34. Arsenic trioxide in a hemodialytic patient with acute promyelocytic leukemia.
    Yamamoto Y; Sasaki M; Oshimi K; Sugimoto K
    Acta Haematol; 2009; 122(1):52-3. PubMed ID: 19816009
    [No Abstract]   [Full Text] [Related]  

  • 35. Protein kinase C is involved in arsenic trioxide-induced apoptosis and inhibition of proliferation in human bladder cancer cells.
    Wang Y; An R; Dong X; Pan S; Duan G; Sun X
    Urol Int; 2009; 82(2):214-21. PubMed ID: 19322013
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Antitumor activity of arsenic trioxide on retinoblastoma: cell differentiation and apoptosis depending on arsenic trioxide concentration.
    Kim JH; Kim JH; Yu YS; Kim DH; Kim CJ; Kim KW
    Invest Ophthalmol Vis Sci; 2009 Apr; 50(4):1819-23. PubMed ID: 19060284
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Inhibition on LS-174T cell growth and activity of telomerase in vitro and in vivo by arsenic trioxide.
    Wang X; Wang G; Dong D; Fu S; Yang B
    Exp Toxicol Pathol; 2008 Sep; 60(6):481-8. PubMed ID: 18606528
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Clinical relevance of "late" in the management of late relapse after treatment for a germ cell tumor.
    Toner GC
    J Clin Oncol; 2008 Dec; 26(34):5502-3. PubMed ID: 18936469
    [No Abstract]   [Full Text] [Related]  

  • 39. The value of post-chemotherapy surgery for residual disease in ovarian germ cell tumors.
    Naik R
    J Postgrad Med; 2006; 52(4):245-6. PubMed ID: 17191355
    [No Abstract]   [Full Text] [Related]  

  • 40. Arsenic trioxide induced the apoptosis of laryngeal cancer via down-regulation of survivin mRNA.
    Cheng B; Yang X; Han Z; An L; Liu S
    Auris Nasus Larynx; 2008 Mar; 35(1):95-101. PubMed ID: 17869043
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.